# A population pharmacokinetic study of ampicillin therapy in hospitalized foals

## TL;DR

This study examines how ampicillin is processed in hospitalized foals and suggests optimal dosing strategies to ensure effective treatment.

## Contribution

The paper introduces a population pharmacokinetic model for ampicillin in foals and proposes dosing adjustments based on MIC and clinical needs.

## Key findings

- A 2-compartment model best describes ampicillin pharmacokinetics in foals, with age affecting clearance and volume.
- Ampicillin dosing of 20 mg/kg every 6 hours achieves optimal PTA for MICs up to 0.25 mg/L.
- Higher doses or more frequent administration are needed for higher MICs or stricter targets.

## Abstract

Pharmacokinetic studies on ampicillin in foals are limited, underscoring a relevant gap in knowledge, particularly regarding the treatment of critically ill neonatal foals.

To evaluate the adequacy of the ampicillin dosing regimen in hospitalized foals and, if necessary, suggest alternative dosing strategies to achieve effective ampicillin concentrations.

Data were collected from 12 hospitalized foals.

Foals were treated with 20 mg/kg ampicillin intravenously every 6 h. Plasma samples were obtained within the first 48 h, and the minimum inhibitory concentration (MIC) was determined for pathogen-positive patients. Ampicillin concentrations were quantified using liquid chromatography–tandem mass spectrometry. A population pharmacokinetic model was developed using a nonlinear mixed-effects approach (stochastic approximation expectation–maximization or SAEM algorithm), and a pharmacodynamic evaluation of different dose regimens was conducted using Monte Carlo simulations.

A 2-compartment model with first-order elimination was selected. Age significantly influenced peripheral compartment volume and clearance. The model demonstrated excellent internal validation, with 97% of observed values within prediction intervals and robust stability, as confirmed by bootstrap and visual predictive checks. Pharmacodynamic simulations indicated that a dosage regimen of 20 mg/kg every 6 h achieved optimal PTA (≥90%) for MICs of 0.06-0.25 mg/L with a 50% fT > MIC target. For higher MICs or a 100% fT > MIC target, more frequent dosing (q4h) and higher doses (30-40 mg/kg) were necessary.

The results from the simulations highlight the clinical importance of adjusting dosing regimens based on foal characteristics and MIC to ensure effective treatment, especially in critically ill foals.